Background: Placenta accreta is characterized by abnormal invasion of placental villi into the uterine wall. We present a case of placenta accreta complicating a dichorionic diamniotic twin pregnancy, requiring emergent delivery by caesarean hysterectomy.
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Background: Placenta accreta is characterized by abnormal invasion of placental villi into the uterine wall. We present a case of placenta accreta complicating a dichorionic diamniotic twin pregnancy, requiring emergent delivery by caesarean hysterectomy.
Case Presentation: Mrs SO was a 36-year-old lady, G3P2, who presented to Westmead Hospital's labor ward at 30 weeks and 2 days gestation with fulminant HELLP syndrome, preeclampsia and evidence of foetal distress. Her presentation was in the context of a dichorionic diamniotic twin pregnancy complicated by a known accreta of twin 2's placenta. The decision was taken for transfer to theatres for an emergency caesarean hysterectomy. Both twins were delivered by breech extraction before the placenta of twin 1 was removed by continuous cord traction. The uterus was closed routinely, leaving the placenta of twin 2 in situ and removed en bloc by hysterectomy. Mrs SO required admission to ICU post-operatively prior to discharge home 7 days after her presentation.
Conclusions: Placenta accreta is an uncommon obstetric complication, especially in cases of multiple gestations while the association with pre-eclampsia is not remains uncertaine. Optimal management involves multidisciplinary planning in the antenatal setting, with input from interventional radiologists, gynaecological oncologists, anaesthetists and directed by a team of obstetricians. However, we highlight the point that in circumstances when this is not possible, ensuring the availability of senior staff at time of the caesarean hysterectomy is associated with significantly improved intraoperative and postoperative outcomes.
SUCCESSFUL DELAYED-INTERVAL DELIVERY IN MONOCHORIONIC DIAMNIOTIC TWIN PREGNANCY
Blacktown Hospital, Blacktown, Australia Email: tanja_baltus@hotmail.com Background: Delayed-interval delivery in twin pregnancy is a rare occurrence and can be performed in twin pregnancies when the first twin is born at the limit of viabililty to improve outcome of the second twin. It is suggested that monochorionicity is a contraindication to delayed-interval delivery due risks to the remaining foetus. In the literature only a handful of cases are described.
Methods: We describe a case of successful delayed-interval delivery of monochorionic diamniotic (MCDA) twins with survival of the second twin.
Results: A 33-year-old with an MCDA twin pregnancy presented at 20 weeks of gestation with preterm premature rupture of membranes. At 23 weeks and 2 days, a 555-g infant was delivered via vaginal breech delivery and no resuscitation was initiated.
After delivery of the first twin, the umbilical cord was ligated high in the vagina. Due to suspected chorioamnionitis she was induced with an oxytocin infusion at 24 + 1 weeks. A 698-g neonate delivered via vaginal breech and received full resuscitation. Following multidisciplinary discussion, we decided not to initiate resuscitation before 24 weeks of gestational age. The first neonate died on the first day off life. Due to a successful delayed-interval delivery of six days the second twin survived. There were no neonatal nor maternal complications.
Conclusions: Our case suggests that delayed-interval delivery of the second foetus in MCDA twins is feasible in a closely monitored environment. Background: Myasthenia Gravis (MG) is an uncommon autoimmune disorder of neuromuscular transmission characterized by weakness of skeletal muscles. MG has a prevalence of 1 in 20 000 pregnancies. MG often targets women of childbearing age, but it remains rare for the diagnosis to be made during pregnancy.
ANTI-MUSK MYASTHENIA GRAVIS IN PREGNANCY
MG associated with antibodies against the muscle-specific receptor tyrosine kinase (anti-MuSK) has a poorer response to treatment in the general population, however given rarity of the disease management of anti-MuSK MG remains controversial in pregnancy.
Methods: We report a case of anti-MuSK MG in pregnancy and successful treatment.
Results: A 30-year-old nulliparous woman presented at 32 weeks gestational age with diplopia, proximal upper limb weakness and left horizontal gaze palsy.
The diagnosis of anti-MuSK MG was made based on positive repetitive nerve stimulation and positive anti-muscle-specific kinase antibodies. She was started on oral prednisone (10 mg daily which was slowly increased to 25 mg daily) and intravenous immunoglobulin (IVIg) 0.4 g/kg body weight daily for 5 days and then monthly.
Our patient had a good response to treatment with improvement of symptoms. She underwent a caesarean section at term due to decreased fetal movements. There were no signs of transient neonatal MG and there were no further maternal complications.
Conclusions: This case report adds to the body of knowledge regarding MG in pregnancy. The benefit of therapy remains uncertain at present and requires further evaluation.
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